hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06349902 id: Pro00077561 briefTitle: Re-link HCV in Substance-Use Telemedicine Program overallStatus: RECRUITING date: 2024-03-12 date: 2024-08-31 date: 2024-12-31 date: 2024-04-05 date: 2024-04-05 name: trueNorth Medical Centres class: OTHER name: Gilead Sciences briefSummary: This is an observational, retrospective \& prospective cohort study. The retrospective element of the study is a chart review to identify people with diagnosed but untreated HCV and re-link them to care. The observational prospective cohort element of the study will examine the HCV linkage to care, treatment initiation, treatment completion \& cure rates of these HCV clients achieved through this chart review and re-linking approach. conditions: Hepatitis C studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: OTHER count: 5000 type: ESTIMATED name: Re-Link measure: number of patients identified as having diagnosed but untreated HCV measure: percentage of patients identified as having diagnosed but untreated HCV that are re-linked to HCV care measure: treatment initiation rates measure: treatment completion dates measure: cure rates sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: trueNorth Medical Centre status: RECRUITING city: Toronto state: Ontario zip: M5B 2A5 country: Canada name: Hannah O'Reilly, BSc role: CONTACT phone: 8888783563 phoneExt: 6452 email: hannah.oreilly@truenorthmedical.com role: CONTACT phoneExt: Cavacuiti email: drccavacuiti@truenorthmedical.com name: Chris Cavacuiti, BA, MD, MHSc role: PRINCIPAL_INVESTIGATOR lat: 43.70011 lon: -79.4163 hasResults: False
nctId: NCT06349889 id: MA-NPC-II-004 briefTitle: Adebrelimab and Chemoradiotherapy in High-risk Locoregionally Advanced Nasopharyngeal Carcinoma overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2028-05-01 date: 2028-05-01 date: 2024-04-05 date: 2024-04-09 name: Sun Yat-sen University class: OTHER name: Nanfang Hospital, Southern Medical University name: West China Hospital briefSummary: This trial aims to study the role of Adebrelimab combined with induction chemotherapy plus concurrent chemoradiotherapy (IC+CCRT) for high-risk locoregionally advanced nasopharyngeal carcinoma(LANPC). conditions: Nasopharyngeal Carcinoma conditions: Nasopharyngeal Cancer studyType: INTERVENTIONAL phases: PHASE2 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 50 type: ESTIMATED name: Adebrelimab measure: Failure-free survival (FFS) measure: Overall survival (OS) measure: Distant metastasis-free survival (DMFS) measure: Locoregional recurrence-free survival (LRRFS) measure: Adverse events (AEs) and serious adverse events (SAEs) measure: Quality of life (QoL) measure: Failure-free survival (FFS) within different subgroups sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Nanfang Hospital, Southern Medical University city: Guangzhou state: Guangdong zip: 510000 country: China name: Jian Guan, M.D. role: CONTACT lat: 23.11667 lon: 113.25 facility: West China Hospital, Sichuan University city: Chengdu state: Sichuan zip: 610000 country: China name: Lei Liu, M.D. role: CONTACT lat: 30.66667 lon: 104.06667 hasResults: False
nctId: NCT06349876 id: SUEZ MED - IRB Approval NO: 6 briefTitle: Cholecystectomy in Patients With Silent Common Bile Duct Stones overallStatus: COMPLETED date: 2023-02-15 date: 2023-07-15 date: 2024-01-15 date: 2024-04-05 date: 2024-04-23 name: Suez University class: OTHER briefSummary: Aim of this study is to evaluate the efficacy of performing only cholecystectomy in patients with asymptomatic common bile duct stones without dealing with common bile duct stones conditions: Performing Cholecystectomy in Patients With Chronic Calcular Choleycystits studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 60 type: ACTUAL name: laparoscopic cholecystectomy measure: number of patients developed jaundice post cholecystectomy sex: ALL minimumAge: 25 Years maximumAge: 60 Years stdAges: ADULT facility: Qeft Teatching Hospital city: Qinā country: Egypt lat: 26.16418 lon: 32.72671 facility: Qena Faculty of Medicine city: Qinā country: Egypt lat: 26.16418 lon: 32.72671 facility: Suez Faculty of Medicine city: Suez zip: 43221 country: Egypt lat: 29.97371 lon: 32.52627 hasResults: False
nctId: NCT06349863 id: W23.225 briefTitle: Dutch CHolEcystitis Snapshot Study acronym: Dutch-CHESS overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2024-10-31 date: 2025-04-30 date: 2024-04-05 date: 2024-04-11 name: St. Antonius Hospital class: OTHER name: St. Antonius Onderzoeksfonds name: Dutch Snapshot Research Group name: Nederlandse Leverpatientenvereniging briefSummary: Background: Cholecystitis is treated by in various types of hospitals by different specialists, and treatment strategy is influenced by logistical and medical reasons and personal preference. This may significantly impact hospital stay and other outcomes.
Methods: Nation-wide cohort study of all patients diagnosed and treated for cholecystitis during a 6 month period. The primary outcome will be the proportion of patients with an acute cholecystitis in which the guideline is followed. This group will be compared to those in which the guideline is not followed, focussing on total hospital stay and complications. Secondary aims are to determine: factors related to guideline compliance; the best method of cystic duct closure; the best treatment strategy for a \>7-day existing cholecystitis; factors predictive for concomitant common bile duct stones; strategies following gallbladder drainage. Multivariable analysis and propensity score matching will be used when appropriate for the etiological study aims. The TRIPOD guideline for prediction modelling will be used for the predictive study aims. Hospitals will receive their own results, set out against the national average and best practices, thereafter subsequent changes in hospital practice will be recorded.
Conclusion: This study will determine the variation in treatment of cholecystitis in the Netherlands and its impact on clinical outcome. Its results will serve as an important incentive to create optimal, uniform cholecystitis treatment in the Netherlands. conditions: Cholecystitis conditions: Cholecystitis; Gallstone conditions: Cholecystitis; Choledocholithiasis studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 3000 type: ESTIMATED measure: Total hospital stay sex: ALL minimumAge: 18 Years maximumAge: 120 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06349850 id: Soh-Med-24-03-06MS briefTitle: Predictive Value of Serum Uric Acid to High Density Lipoprotein Cholesterol Ratio for Diabetic Kidney Injury in Type 2 Diabetes overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-09 date: 2024-09 date: 2024-04-05 date: 2024-04-05 name: Sohag University class: OTHER briefSummary: An prospective observetional study to asses the predictive value of serum uric acid to high density lipoprotein cholesterol ratio for diabetic kidney injury in type 2 diabetes conditions: Diabetic Kidney Disease studyType: OBSERVATIONAL observationalModel: CASE_CROSSOVER timePerspective: PROSPECTIVE count: 100 type: ESTIMATED name: serum uric acid level to plasma HDL-c level ratio (UHR) measure: Uric acid to HDL-c ratio (UHR) sex: ALL minimumAge: 18 Years maximumAge: 90 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06349837 id: ECLIPSE-02 briefTitle: Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors overallStatus: NOT_YET_RECRUITING date: 2024-04-15 date: 2025-03-31 date: 2026-03-31 date: 2024-04-05 date: 2024-04-05 name: Sichuan University class: OTHER briefSummary: This is a 3+3 dose escalation phase I study which aims to evaluate the safety and tolerability of low dose radiotherapy (LDRT) plus concurrent partial Stereotactic Ablative Radiotherapy (SBRT) and Tislelizumab in Patients with bulky tumors who have failed standard therapy. At least 9 participants will be enrolled in this study. conditions: Solid Tumor studyType: INTERVENTIONAL phases: PHASE1 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 9 type: ESTIMATED name: Tislelizumab name: Low Dose Radiotherapy name: Stereotactic Ablative Radiotherapy measure: Dose Limiting Toxicities measure: Objective Response Rate (ORR) measure: Progression Free Survival (PFS) measure: Overall Survival (OS) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06349824 id: 004AEstb/EC/01/2022 briefTitle: Dextrose, Steroid, PRP: Choosing the Right Injection for CRS Relief; a RCT overallStatus: COMPLETED date: 2023-10-10 date: 2024-03-30 date: 2024-03-30 date: 2024-04-05 date: 2024-04-05 name: Sheikh Zayed Medical College class: OTHER_GOV briefSummary: USG guided injections to relieve carpal tunnel syndrome with dextrose water or steroid or PRP conditions: Carpal Tunnel Syndrome studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 60 type: ACTUAL name: injection Dextrose water name: USG machine measure: VAS sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Sheikh Zayed Medical College city: Rahim yar khan state: Punjab zip: 64200 country: Pakistan lat: 28.41987 lon: 70.30345 hasResults: False
nctId: NCT06349811 id: BL-M05D1-101 briefTitle: A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2026-05 date: 2026-05 date: 2024-04-05 date: 2024-04-09 name: Sichuan Baili Pharmaceutical Co., Ltd. class: INDUSTRY name: Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. briefSummary: This study is an open-label, multicenter, dose-escalation, and extended-enrollment nonrandomized phase I study to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-M05D1 in patients with locally advanced or metastatic solid tumors. conditions: Locally Advanced or Metastatic Solid Tumors studyType: INTERVENTIONAL phases: PHASE1 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 30 type: ESTIMATED name: BL-M05D1 measure: Phase Ia: Dose limiting toxicity (DLT) measure: Phase Ia: Maximum tolerated dose (MTD) measure: Phase Ib: Recommended Phase II Dose (RP2D) measure: Treatment-Emergent Adverse Event (TEAE) measure: Cmax measure: Tmax measure: T1/2 measure: AUC0-t measure: CL (Clearance) measure: Ctrough measure: ADA (anti-drug antibody) measure: Phase Ib: Objective Response Rate (ORR) measure: Phase Ib: Disease Control Rate (DCR) measure: Phase Ib: Duration of Response (DOR) sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Beijing Cancer Hospital city: Beijing state: Beijing country: China name: Lin Shen role: CONTACT lat: 39.9075 lon: 116.39723 hasResults: False
nctId: NCT06349798 id: DR200177 briefTitle: Early and Late Effects of Nefopam in Multimodal Analgesia After Total Hip Arthroplasty (NEFARTHRO) acronym: NEFARTHRO overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2026-09 date: 2027-04 date: 2024-04-05 date: 2024-04-05 name: University Hospital, Tours class: OTHER briefSummary: NEFARTHRO is a multicentric randomized controlled trial comparing the effects of discontinuous infusions of nefopam (bolus) versus continuous infusion of intravenous nefopam (via an infusion pump) versus placebo on the opioid-request during the first 24 hours following a Total Hip arthroplasty, as part of multimodal analgesia including at least paracetamol and a Non-Steroidal Anti-Inflammatory Drug (NSAID).
nctId: NCT06349785 id: P.T.REC/012/003858 briefTitle: Manual Hyperinflation and Physical Therapy Program on Lung Recruitment Mechanically Ventilated Pediatric Patients acronym: MHI overallStatus: COMPLETED date: 2023-12-20 date: 2024-03-01 date: 2024-03-29 date: 2024-04-05 date: 2024-04-05 name: New Ismailia National University class: OTHER briefSummary: The purpose of this study is to investigate the immediate combined effects of Manual Hyperinflation and standard Physical therapy program on lung recruitment and secretion mass in mechanically ventilated pediatric patients aged between 10-15 years 'old conditions: Mechanical Ventilation Complication conditions: Physical Disability studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: randomized controlled trial primaryPurpose: SUPPORTIVE_CARE masking: SINGLE maskingDescription: using sealed envelopes, whoMasked: PARTICIPANT count: 32 type: ACTUAL name: rehabilitation of mechanically ventilated patients name: supportive care measure: change the respiratory functions measure: change the respiratory mechanics measure: change the bronchospasm measure: change the amount of ventilation measure: decreasing the amount of secretions measure: weaning from mechanical ventilator sex: ALL minimumAge: 10 Years maximumAge: 15 Years stdAges: CHILD facility: College of Medicine city: Ismailia zip: 41522 country: Egypt lat: 30.60427 lon: 32.27225 hasResults: False
nctId: NCT06349772 id: FY2024-203 briefTitle: Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2025-04-01 date: 2025-04-01 date: 2024-04-05 date: 2024-04-08 name: Texas Tech University Health Sciences Center class: OTHER briefSummary: The purpose of this study is to evaluate the use of an injectable combination of bupivacaine and meloxicam (Zynrelef) vs injectable liposomal bupivacaine (Exparel), two extended local anesthesia strategies currently approved by FDA and on the market for post-surgical pain control. The investigators plan on randomizing study participants to either Exparel or Zynrelef at the closure site of robotic sleeve gastrectomy and assessing their pain control postoperatively both in the hospital and at home. The investigators will measure the outcome of two drugs, Zynrelief, and Exparel on postoperative pain score -using the NRS pin score up to 72 hours after surgery. The total opioid use will be recorded in forms that will be used to measure pain score and total opioid use and will be collected to the Excel sheet. The cost of the drug will be calculated for internal use for Hospital purpose only. conditions: Post Operative Pain studyType: INTERVENTIONAL phases: EARLY_PHASE1 allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: randomizing study participants to either Exparel or Zynrelef at the closure site of robotic sleeve gastrectomy and assessing their pain control postoperatively primaryPurpose: TREATMENT masking: DOUBLE whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 130 type: ESTIMATED name: Zynrelef name: Exparel measure: postoperative pain score measure: Total postoperative opioid use measure: Proportion of total rescue medication use sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06349759 id: OPI-NYXDLD-302 briefTitle: Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances acronym: LYNX-2 overallStatus: RECRUITING date: 2024-04-01 date: 2025-09 date: 2025-11 date: 2024-04-05 date: 2024-04-08 name: Ocuphire Pharma, Inc. class: INDUSTRY name: Viatris Inc. briefSummary: Safety and efficacy of 0.75% Phentolamine Ophthalmic Solution to improve mesopic low contrast visual acuity in subjects with post-refractive surgery visual disturbances. conditions: Mesopic Vision conditions: Night Vision Loss studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 200 type: ESTIMATED name: phentolamine ophthalmic solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist name: Placebo measure: Percent of subjects with an increase of at least 15 ETDRS letters read (≥ 3 lines) in the study eye in mLCVA compared to Baseline (Day 1 pre-dose) at Day 15 sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: United States, California status: RECRUITING city: Newport Beach state: California zip: 92663 country: United States lat: 33.61891 lon: -117.92895 facility: United States, North Carolina status: RECRUITING city: Garner state: North Carolina zip: 27529 country: United States lat: 35.71126 lon: -78.61417 facility: United States, Rhode Island status: RECRUITING city: Warwick state: Rhode Island zip: 02888 country: United States lat: 41.7001 lon: -71.41617 hasResults: False
nctId: NCT06349746 id: collage of physical therapy briefTitle: Cervical Unilateral Antero-posterior Mobilization and Thoracic Central Postro-anterior Mobilization in Treatment of Shoulder Impingement Syndrome overallStatus: NOT_YET_RECRUITING date: 2024-04-15 date: 2024-05 date: 2024-06 date: 2024-04-05 date: 2024-04-05 name: Egyptian Chinese University class: OTHER name: Benha University briefSummary: Shoulder impingement syndrome (SIS) is a complex, multi-factorial problem that is treated with a variety of different conservative options. The conservative option that has shown effectiveness is manual therapy of the cervical and thoracic spine conditions: Shoulder Impingement studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: this study will be conducted to compare one group receiving selected therapeutic exercises and other group recieve cervical and thoracic mobilization added to selected therapeutic exercise Program on pain intensity, Pain-free shoulder flexion and scaption active ROM, muscle strength of external rotator and abductors, shoulder functional status in patients with Shoulder Impingement Syndrome. primaryPurpose: TREATMENT masking: DOUBLE maskingDescription: patients and outcomes assessor will be masked about the grouping of the study whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 50 type: ESTIMATED name: therapeutic exercises name: mobilization exercise measure: pain intensity measure: shoulder flexion and abduction range of motion measure: muscle strength sex: ALL minimumAge: 20 Years maximumAge: 45 Years stdAges: ADULT hasResults: False
nctId: NCT06349733 id: MR-37-23-008382 briefTitle: Effectiveness of Botulinum Toxin A in Preventing Scar Formation and Initial Exploration of "Optimal Concentration" overallStatus: ACTIVE_NOT_RECRUITING date: 2023-03-23 date: 2023-11-10 date: 2024-04-10 date: 2024-04-05 date: 2024-04-05 name: Qilu Hospital of Shandong University class: OTHER briefSummary: Each year, millions of burn, trauma, or surgical patients worldwide suffer from scarring that severely affects their quality of life and social functioning. In order to prevent and treat diseases related to abnormal scar hyperplasia, clinicians and researchers have adopted various methods, such as scar grinding, surgical resection, drug injection in scar tissue, cryotherapy, laser and so on. However, these methods can not effectively inhibit the abnormal proliferation of scars and improve the adverse effects of existing scars on patients. To date, there is no accepted gold standard for the effective treatment and improvement of abnormal scar tissue. conditions: Scar studyType: INTERVENTIONAL phases: EARLY_PHASE1 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 50 type: ACTUAL name: Botulinum toxin type A measure: The modified Stony Brook Scar Evaluation Scale measure: Patient satisfaction sex: ALL minimumAge: 12 Years maximumAge: 65 Years stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Qilu Hospital of Shandong University Dezhou Hospital city: Dezhou state: Shandong zip: 253000 country: China lat: 37.45127 lon: 116.31046 hasResults: False
nctId: NCT06349720 id: KF-2023-355 briefTitle: Investigating Long-term Health Effects and Complications in COVID-19 Recoveries overallStatus: RECRUITING date: 2023-06-07 date: 2024-06-07 date: 2024-06-07 date: 2024-04-05 date: 2024-04-05 name: Zhaohui Tong class: OTHER briefSummary: Clarify the incidence of functional impairments in cured COVID-19 patients and identify influencing factors. Build a multi-omics database for COVID-19 patients in the recovery period to elucidate the biological biomarkers and targets associated with functional impairments. Comprehensive exploration of the long-term prognosis, complications, sequelae, and risk factors of COVID-19 patients after Omicron infection, as well as their immune characteristics. Compare the impact of different strains of the COVID-19 virus on prognosis and immune response. Develop comprehensive rehabilitation intervention strategies for COVID-19 patients with functional impairments and evaluate the impact of different intervention methods on their prognosis. Based on clinical data, multi-omics data, and precise rehabilitation assessment data, construct predictive models for prognosis and rehabilitation effectiveness in COVID-19, providing scientific evidence for the implementation of effective COVID-19 rehabilitation measures. conditions: COVID-19 Patients studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 17000 type: ESTIMATED name: respiratory rehabilitation measure: Immunological characteristics associated with functional impairments in COVID-19 convalescent patients measure: Changes in laboratory examination indicators measure: High-resolution CT of the chest measure: Pulmonary function test measure: Multi-omics changes and characteristics associated with functional impairments in COVID-19 convalescent patients measure: Inflammatory factors related to body dysfunction in COVID-19 rehabilitation patients measure: Regular rehabilitation assessment following respiratory rehabilitation intervention in COVID-19 patients sex: ALL minimumAge: 18 Years maximumAge: 120 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Beijing Institute of Respiratory Medicine status: RECRUITING city: Beijing state: Beijing zip: 100027 country: China name: Zhaohui Tong, Dr role: CONTACT phone: +86 010 8523 1000 email: 13910930309@163.com lat: 39.9075 lon: 116.39723 hasResults: False
nctId: NCT06349707 id: 2023PI112 briefTitle: Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic acronym: VirCoV+ overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-05 date: 2024-06 date: 2024-04-05 date: 2024-04-05 name: Central Hospital, Nancy, France class: OTHER briefSummary: The hypothesis was that a retrospective investigation of the molecular virological tests in a University hospital could be informative, with the aim to identify non-COVID-19 respiratory viruses during the circulation of SARS-CoV-2, according to systematic population data for public health knowledge. conditions: Viral Pneumonia studyType: OBSERVATIONAL observationalModel: ECOLOGIC_OR_COMMUNITY timePerspective: RETROSPECTIVE count: 18 type: ESTIMATED name: other: Observational measure: Occurrence of positive viral PCR assays (not COVID-19) from hospitalizations for respiratory infections. measure: Real-life features of patients in Intensive care (from the whole population - Outcome 1) with positive viral PCR during infectious pneumonia. sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Schvoerer city: Vandoeuvre Les Nancy zip: 54511 country: France lat: 48.65 lon: 6.18333 hasResults: False